Detalhe da pesquisa
1.
Bruton's Tyrosine Kinase Inhibitors with Distinct Binding Modes Reveal Differential Functional Impact on B-Cell Receptor Signaling.
Mol Cancer Ther
; 23(1): 35-46, 2024 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-37735104
2.
Combinatorial inhibition of Tec kinases BTK and ITK is beneficial in ameliorating murine sclerodermatous chronic graft versus host disease.
Bone Marrow Transplant
; 58(8): 924-935, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37160943
3.
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).
Cancer Cell
; 1(5): 421-32, 2002 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-12124172
4.
Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma.
Mol Cancer Ther
; 16(7): 1246-1256, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28428442
5.
The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma.
Am J Cancer Res
; 6(11): 2489-2501, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27904766